Results 311 to 320 of about 126,024 (329)

Sorafenib

Reactions Weekly, 2022
openaire   +1 more source

Sorafenib

Reactions Weekly, 2020
  +4 more sources

Immunotherapies for hepatocellular carcinoma

Nature Reviews Clinical Oncology, 2021
, Florian Castet, Mala K Maini
exaly  

Sorafenib

Reactions Weekly, 2023
openaire   +2 more sources

Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial

Lancet Oncology, The, 2022
Thomas Yau, Joong-Won Park, Richard S Finn   +2 more
exaly  

Sorafenib

Reactions Weekly, 2011
openaire   +2 more sources

Sorafenib

Reactions Weekly, 2012
openaire   +2 more sources

Recent Progress in the Management of Advanced Renal Cell Carcinoma

Ca-A Cancer Journal for Clinicians, 2007
Brian I Rini
exaly  

m6A RNA methylation-mediated HNF3γ reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistance

Signal Transduction and Targeted Therapy, 2020
Daimin Xiang, Cheng Zhang, Hong-Yang Wang   +2 more
exaly  

Sorafenib

Reactions Weekly, 2015
  +4 more sources